MMP9 and neoplasm: The pro-tumor N2 phenotype is characterized by increased expression of angiogenesis and invasion promoting factors CXCR4, VEGF and MMP-9 with absent IFN-β [78] and is acquired by neutrophils following the TGF-β treatment [77].